CUREYOU PHARMACEUTICALS PRIVATE LIMITED
CUREYOU PHARMACEUTICALS PRIVATE LIMITED is a HARYANA based PRIVATE LIMITED company, Registered at dated 22-APR-2022 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of CUREYOU PHARMACEUTICALS PRIVATE LIMITED is U24100HR2022PTC103069 and registration number is 103069.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies DELHI India. Authorized share capital of CUREYOU PHARMACEUTICALS PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
CUREYOU PHARMACEUTICALS PRIVATE LIMITED has 2 directors RAHUL BANSAL, SHALLU GUPTA,
The registered Email address of CUREYOU PHARMACEUTICALS PRIVATE LIMITED is CUREYOUPHARMA@GMAIL.COM and its registered address is SHOP NO. 292 SECTOR 21 ROAD, MAHESHPUR PANCHKULA PANCHKULA HR 134116 IN HARYANA HARYANA india 134116.
The current status of CUREYOU PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
CUREYOU PHARMACEUTICALS PRIVATE LIMITED
DELHI
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24100HR2022PTC103069
22-APR-2022
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
100000
CONTACT DETAILS
134116
INDIA
SHOP NO. 292 SECTOR 21 ROAD, MAHESHPUR PANCHKULA PANCHKULA HR 134116 IN
CUREYOUPHARMA@GMAIL.COM
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
09582284 | RAHUL BANSAL | Director | 22/04/2022 |
09582285 | SHALLU GUPTA | Director | 22/04/2022 |
Details Updated by Companies
Quick Links
- All Registered company of HARYANA
- Company Registered in HARYANA
- All Registered company of PANCHKULA in HARYANA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.